Isis Pharmaceuticals
to Host Investor Event to Discuss
ISIS-SMNRx Data
Presented at 2014 AAN Annual Meeting

April 29, 2014 at 6:00 p.m. ET
Le Méridien Hotel - Ballroom-Salon I, 3rd Floor
1421 Arch Street – Philadelphia, PA

Register Now for the Live Event or to Listen to the Webcast

Current Advances

Reduction of a Novel Energy-Regulating Target with Antisense Compound Protects against Diet-induced Weight Gain and Enhances Insulin Sensitivity

Learn More